Medical Mitogen-activated protein kinases (MAPK) Research

anti- Phospoho CDK, MAPK, GSK3, CLK, ERK1/2, JNK

ATE1 inhibits liver cancer progression through RGS5-mediated suppression of Wnt/β-catenin signaling
Ae1 Ae3 Antibody Bafilomycin A1 Bile Acid Assay Bioassay Blog cDNA Ch 223191 Choline Acetyltransferase Antibody exosome F Actin Antibody Glycodeoxycholic Acid Isotype Ldn 193189 Medium Mip 1B Mmp Activity Assay Polyclonal Ru 58841 Soft Agar Tubastatin A Uric Acid Assay Valproic Acid Sodium Salt Western Blot

ATE1 inhibits liver cancer progression through RGS5-mediated suppression of Wnt/β-catenin signaling

Arginyltransferase (ATE1) performs vital roles in lots of organic features together with cardiovascular growth, angiogenesis, adipogenesis, muscle contraction, and metastasis of most cancers. Nonetheless, the position of ATE1 in hepatocellular carcinoma (HCC) stays unknown. On this research, we discover that ATE1 performs an important position in progress and malignancy of liver most cancers.
ATE1 expression is considerably decreased in human HCC samples in comparison with regular liver tissue. Moreover, low ATE1 expression is correlated with aggressive clinicopathological options and is an unbiased poor prognostic issue for total survival and disease-free survival of HCC sufferers. Lentivirus-mediated ATE1 knockdown considerably promoted liver most cancers progress, migration and illness development in vitro and in vivo.
Opposing outcomes had been noticed when ATE1 was up-regulated. Mechanistically, ATE1 accelerated the degradation of β-catenin and inhibited Wnt signaling by regulating turnover of Regulator Of G Protein Signaling 5 (RGS5). Loss- and gain-of-function assays confirmed that RGS5 was a key effector of ATE1-mediated regulation of Wnt signaling.
Additional research indicated that RGS5 could be concerned in regulating the exercise of GSK3-β, a vital element of the cytoplasmic destruction complicated. Remedy with a GSK inhibitor (CHIR99021) cooperated with ablation of ATE1 or RGS5 overexpression to advertise Wnt/β-catenin signaling, however overexpression of ATE1 or RGS5 knockdown didn’t reverse the impact of GSK inhibitor. Implications: ATE1 inhibits liver most cancers development by suppressing Wnt/β-catenin signaling and may function a probably useful prognostic biomarker for HCC.

AGEs promote calcification of HASMCs by mediating Pi3k/AKT-GSK3β signaling

This research aimed to research the consequences of superior glycation finish merchandise (AGEs) on the calcification of human arterial easy muscle cells (HASMCs) and to discover whether or not AGEs can promote the calcification of HASMCs by activating the phosphoinositide 3-kinase (PI3K)/AKT-glycogen synthase kinase Three beta (GSK3-β) axis. Cultured HASMCs had been divided into 5 teams: clean management group, dimethyl sulfoxide (automobile) group, AGEs group, LY294002 (AKT inhibitor) group, and TWS119 (GSK3-β inhibitor) group.
Cells had been pretreated with both automobile, LY294002, or TWS119 for two hours adopted by incubation with AGEs (25 μg/mL) for five days, and the expression ranges of proteins in every group had been analyzed by western blotting. AGE therapy promoted HASMC calcification, which coincided with elevated expression of p-AKT and p-GSK3-β (serine 9).
Additionally, AGEs upregulated the expression of osteoprotegerin and bone morphogenetic protein, and these results had been suppressed by LY294002 however enhanced by TWS119. In conclusion, AGEs promote calcification of HASMCs, and this impact is ameliorated by inhibition of AKT exercise however potentiated by inhibition of GSK3-β exercise. Therefore, AGEs set off HASMC calcification by regulating PI3K/AKT-GSK3-β signaling.

GSK3 Inhibitor-Induced Dentinogenesis Utilizing a Hydrogel

Small-molecule medication concentrating on glycogen synthase kinase 3 (GSK3) as inhibitors of the protein kinase exercise are capable of stimulate reparative dentine formation. To develop this method right into a viable medical therapy for uncovered pulp lesions, we synthesized a novel, small-molecule noncompetitive adenosine triphosphate (ATP) drug that may be included right into a biodegradable hydrogel for placement by syringe into the tooth.
This new drug, named NP928, belongs to the thiadiazolidinone (TDZD) household and has equal exercise to related medication of this household equivalent to tideglusib. Nonetheless, NP928 is extra water soluble than different TDZD medication, making it extra appropriate for direct supply into pulp lesions.
We have now beforehand reported that biodegradable marine collagen sponges can efficiently ship TDZD medication to pulp lesions, however this entails in-theater preparation of the fabric, which isn’t best in a medical context.
To enhance surgical dealing with and supply, right here we included NP928 right into a particularly tailor-made hydrogel that may be positioned by syringe right into a broken tooth. This hydrogel is predicated on biodegradable hyaluronic acid and might be gelled in situ upon dental blue gentle publicity, equally to different frequent dental supplies.
NP928 launched from hyaluronic acid-based hydrogels upregulated Wnt/β-catenin exercise in pulp stem cells and fostered reparative dentine formation in comparison with marine collagen sponges delivering equal concentrations of NP928. This drug-hydrogel mixture has the potential to be quickly developed right into a therapeutic process that’s amenable to normal dental follow.

Direct P70S6K1 inhibition to exchange dexamethasone in synergistic mixture with MCL-1 inhibition in a number of myeloma

Novel mixture therapies have markedly improved the lifespan of sufferers with a number of myeloma (MM), however drug resistance and illness relapse stay main medical issues. Dexamethasone and different glucocorticoids are a cornerstone of standard and new mixture therapies for MM, though their use is accompanied by critical unwanted side effects.
We aimed to uncover drug combos that act in synergy and, as such, enable decreased dosing whereas remaining efficient. Dexamethasone and the myeloid cell leukemia 1 (MCL-1) inhibitor S63845 (MCL-1i) proved probably the most potent mixture in our lethality display screen and induced apoptosis of human myeloma cell strains (HMCLs) that was 50% greater in contrast with an additive drug impact.
Kinome evaluation of dexamethasone-treated HMCLs revealed a discount in serine/threonine peptide phosphorylation, which was predicted to consequence from decreased Akt exercise. Biochemical methods confirmed no dexamethasone-induced results on FOXO protein or GSK3 however did present a 50% discount in P70S6K phosphorylation, downstream of the Akt-mTORC1 axis.
Changing dexamethasone by the P70S6K1 isoform-specific inhibitor PF-4708671 (S6K1i) revealed related and statistically important synergistic apoptosis of HMCLs together with MCL-1i. Apparently, apoptosis induced by the P70S6K1i and MCL-1i mixture was more-than-additive in all 9 main MM samples examined; this impact was noticed for six of 9 samples with the dexamethasone and MCL-1i mixture.

GSK3b antibody
70R-11869 100 ug
EUR 501.6
Description: Rabbit polyclonal GSK3b antibody

GSK3B antibody
70R-15005 100 ul
EUR 470.4
Description: Rabbit polyclonal GSK3B antibody

GSK3B antibody
70R-17615 50 ul
EUR 522
Description: Rabbit polyclonal GSK3B antibody

GSK3B Antibody
36918-100ul 100ul
EUR 302.4

GSK3B Antibody
ABD6806 100 ug
EUR 525.6

GSK3B Antibody
ABD7231 100 ug
EUR 525.6

GSK3B Antibody
1-CSB-PA009963GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat, Pig. This antibody is Unconjugated. Tested in the following application: ELISA, WB

GSK3B Antibody
1-CSB-PA009963LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF; Recommended dilution: WB:1:2000-1:10000, IF:1:50-1:500

GSK3B Antibody
1-CSB-PA009038
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000

GSK3B Antibody
1-CSB-PA080166
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC;WB:1:1000-2000.IHC:1:200-500

GSK3B Antibody
CSB-PA939628- each
EUR 402
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

GSK3B Antibody
CSB-PA939628-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

GSK3B Antibody
1-CSB-PA002848
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.ELISA:1/20000

GSK3B Antibody
F51046-0.08ML 0.08 ml
EUR 140.25
Description: GSK3B is a constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. May also mediate the development of insulin resistance by regulating activation of transcription factors. [UniProt]

GSK3B Antibody
F51046-0.4ML 0.4 ml
EUR 322.15
Description: GSK3B is a constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. May also mediate the development of insulin resistance by regulating activation of transcription factors. [UniProt]

Gsk3b Antibody
F44221-0.08ML 0.08 ml
EUR 140.25
Description: Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. May phosphorylate MUC1 and decrease the interaction of MUC1 with CTNNB1/beta-catenin. Phosphorylates CTNNB1/beta-catenin. Phosphorylates SNAI1 (By similarity).

Gsk3b Antibody
F44221-0.4ML 0.4 ml
EUR 322.15
Description: Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. May phosphorylate MUC1 and decrease the interaction of MUC1 with CTNNB1/beta-catenin. Phosphorylates CTNNB1/beta-catenin. Phosphorylates SNAI1 (By similarity).

GSK3A / GSK3B Antibody
20-abx328487
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

GSK3A/GSK3B Antibody
1-CSB-PA002838
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSK3A/GSK3B. Recognizes GSK3A/GSK3B from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

GSK3B (pY216) Antibody
20-abx123289
  • EUR 594.00
  • EUR 844.80
  • EUR 260.40
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

GSK3B (pY216) Antibody
20-abx000312
  • EUR 594.00
  • EUR 844.80
  • EUR 260.40
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

GSK3B Conjugated Antibody
C38353 100ul
EUR 476.4

GSK3B Conjugated Antibody
C36918 100ul
EUR 476.4

GSK3B Polyclonal Antibody
A72446
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

GSK3B Polyclonal Antibody
A72447
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

GSK3B Polyclonal Antibody
A72448
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

GSK3B Polyclonal Antibody
A72450
  • EUR 377.30
  • EUR 577.50
  • 50 ul
  • 100 ul

GSK3B Polyclonal Antibody
A62706
  • EUR 684.66
  • EUR 117.70
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

GSK3 beta Antibody / GSK3B
F54007-0.1ML 0.1 ml
EUR 322.15
Description: Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. [UniProt]

GSK3B (Ab-9) Antibody
CSB-PA120951- each
EUR 402
Description: A polyclonal antibody against GSK3B (Ab-9). Recognizes GSK3B (Ab-9) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

GSK3B (Ab-9) Antibody
CSB-PA120951-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against GSK3B (Ab-9). Recognizes GSK3B (Ab-9) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

GSK3B (pS21 / 29) Antibody
abx031864-400ul 400 ul
EUR 627.6

GSK3B (pS21 / 29) Antibody
abx031864-80l 80 µl
EUR 343.2

GSK3B Antibody, HRP conjugated
1-CSB-PA009963LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

GSK3A / GSK3B (pY279 / 216) Antibody
abx333212-100ul 100 ul
EUR 560.4

GSK3A / GSK3B (pY279 / 216) Antibody
20-abx328488
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

GSK3B Antibody, FITC conjugated
1-CSB-PA009963LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

GSK3B Antibody, Biotin conjugated
1-CSB-PA009963LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GSK3B. Recognizes GSK3B from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Rabbit Anti-Human GSK3B (aa 214-218) Polyclonal Antibody
CPB-1178RH 100 ul
EUR 552

GSK3B Polyclonal Conjugated Antibody
C30706 100ul
EUR 476.4

Polyclonal GSK3B / GSK3 Beta Antibody
AMM05221G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GSK3B / GSK3 Beta . This antibody is tested and proven to work in the following applications:

Antibody for Human GSK3b (pSer9)
SPC-1384D 0.1ml
EUR 424.8
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is unconjugated.

Antibody for Human GSK3b (pSer9)
SPC-1384D-A390 0.1ml
EUR 481.2
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 390.

Antibody for Human GSK3b (pSer9)
SPC-1384D-A488 0.1ml
EUR 480
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 488.

Antibody for Human GSK3b (pSer9)
SPC-1384D-A565 0.1ml
EUR 480
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 565.

Antibody for Human GSK3b (pSer9)
SPC-1384D-A594 0.1ml
EUR 480
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 594.

Antibody for Human GSK3b (pSer9)
SPC-1384D-A633 0.1ml
EUR 480
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 633.

Antibody for Human GSK3b (pSer9)
SPC-1384D-A655 0.1ml
EUR 480
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 655.

Antibody for Human GSK3b (pSer9)
SPC-1384D-A680 0.1ml
EUR 480
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 680.

Antibody for Human GSK3b (pSer9)
SPC-1384D-A700 0.1ml
EUR 480
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to ATTO 700.

Antibody for Human GSK3b (pSer9)
SPC-1384D-ALP 0.1ml
EUR 472.8
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Alkaline Phosphatase.

Antibody for Human GSK3b (pSer9)
SPC-1384D-APC 0.1ml
EUR 478.8
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to APC .

Antibody for Human GSK3b (pSer9)
SPC-1384D-APCCY7 0.1ml
EUR 565.2
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to APC/Cy7.

Antibody for Human GSK3b (pSer9)
SPC-1384D-BI 0.1ml
EUR 475.2
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Biotin.

Antibody for Human GSK3b (pSer9)
SPC-1384D-DY350 0.1ml
EUR 496.8
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 350.

Antibody for Human GSK3b (pSer9)
SPC-1384D-DY405 0.1ml
EUR 483.6
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 405.

Antibody for Human GSK3b (pSer9)
SPC-1384D-DY488 0.1ml
EUR 471.6
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 488.

Antibody for Human GSK3b (pSer9)
SPC-1384D-DY594 0.1ml
EUR 474
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 594.

Antibody for Human GSK3b (pSer9)
SPC-1384D-DY633 0.1ml
EUR 468
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Dylight 633.

Antibody for Human GSK3b (pSer9)
SPC-1384D-FITC 0.1ml
EUR 470.4
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to FITC.

Antibody for Human GSK3b (pSer9)
SPC-1384D-HRP 0.1ml
EUR 465.6
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to HRP.

Antibody for Human GSK3b (pSer9)
SPC-1384D-P594 0.1ml
EUR 488.4
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to PE/ATTO 594.

Antibody for Human GSK3b (pSer9)
SPC-1384D-PCP 0.1ml
EUR 478.8
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to PerCP.

Antibody for Human GSK3b (pSer9)
SPC-1384D-RPE 0.1ml
EUR 476.4
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to RPE .

Antibody for Human GSK3b (pSer9)
SPC-1384D-STR 0.1ml
EUR 477.6
Description: A polyclonal antibody for GSK3b (pSer9) from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human GSK3b around the phosphorylation site of serine 9 (pSer9).. The Antibody is tested and validated for WB, IHC, IP assays with the following recommended dilutions: WB (1:250-1:1000); IHC (1:25-1:100); IP (Various dilutions). This GSK3b (pSer9) antibody is conjugated to Streptavidin.

GSK3A / GSK3B (Ab-279 / 216) Antibody
abx332166-100ul 100 ul
EUR 510

GSK3A/GSK3B (Ab-279/216) Antibody
CSB-PA255909- each
EUR 402
Description: A polyclonal antibody against GSK3A/GSK3B (Ab-279/216). Recognizes GSK3A/GSK3B (Ab-279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000

GSK3A/GSK3B (Ab-279/216) Antibody
CSB-PA255909-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against GSK3A/GSK3B (Ab-279/216). Recognizes GSK3A/GSK3B (Ab-279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000

Monoclonal GSK3B Antibody, Clone: 3D6B4
AMM05223G 0.1ml
EUR 633.6
Description: A Monoclonal antibody against Human GSK3B. The antibodies are raised in Mouse and are from clone 3D6B4. This antibody is applicable in WB and IHC, FC, E

[KO Validated] GSK3B Polyclonal Antibody
30706-100ul 100ul
EUR 302.4

[KO Validated] GSK3B Polyclonal Antibody
30706-50ul 50ul
EUR 224.4

Rabbit Anti-Human GSK3B Polyclonal Antibody, Phospho-Tyr216
CPB-820RH 100 ul
EUR 670.8

GSK3B Polyclonal Antibody, HRP Conjugated
A62707
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Anti-Glycogen synthase kinase 3 B (GSK3B) (Ser9) antibody
STJ120111 100 µl
EUR 631.2

GSK3B Polyclonal Antibody, FITC Conjugated
A62708
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Rabbit Anti-GSK3A, GSK3B monoclonal antibody, clone TZ37-16
CABT-L635 100 ul
EUR 932.4

GSK3B Polyclonal Antibody, Biotin Conjugated
A62709
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Phospho-GSK3A/GSK3B (Y279/216) Antibody
1-CSB-PA000535
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Phospho-GSK3A/GSK3B (Y279/216). Recognizes Phospho-GSK3A/GSK3B (Y279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

Phospho-GSK3A/GSK3B (Tyr279/216) Antibody
CSB-PA575559- each
EUR 402
Description: A polyclonal antibody against Phospho-GSK3A/GSK3B (Tyr279/216). Recognizes Phospho-GSK3A/GSK3B (Tyr279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200

Phospho-GSK3A/GSK3B (Tyr279/216) Antibody
CSB-PA575559-100ul 100ul
EUR 434.4
Description: A polyclonal antibody against Phospho-GSK3A/GSK3B (Tyr279/216). Recognizes Phospho-GSK3A/GSK3B (Tyr279/216) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200

Polyclonal Mouse Gsk3b Antibody (N-term)
APR04027G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Mouse Gsk3b (N-term). This antibody is tested and proven to work in the following applications:

Polyclonal GSK3B / GSK3 Beta Antibody (C-Terminus)
AMM05222G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GSK3B / GSK3 Beta (C-Terminus). This antibody is tested and proven to work in the following applications:

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx318062
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx233673-100ug 100 ug
EUR 577.2

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx233674-100ug 100 ug
EUR 577.2

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx233675-100ug 100 ug
EUR 661.2

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx233676-100ug 100 ug
EUR 610.8

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx224101-100ug 100 ug
EUR 493.2

Glycogen Synthase Kinase 3 Beta (GSK3b) Antibody
20-abx176674
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Glycogen Synthase Kinase 3 Beta (GSK3b) Antibody
20-abx176675
  • EUR 1562.40
  • EUR 744.00
  • 1 mg
  • 200 ug

Glycogen Synthase Kinase 3 Beta (GSK3b) Antibody
20-abx172635
  • EUR 1028.40
  • EUR 526.80
  • 1 mg
  • 200 ug

Glycogen Synthase Kinase 3 Beta (GSK3b) Antibody
20-abx172636
  • EUR 1095.60
  • EUR 560.40
  • 1 mg
  • 200 ug

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx147405-100ug 100 ug
EUR 526.8

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx332790-100ul 100 ul
EUR 510

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx330217
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx332014-100ul 100 ul
EUR 510

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx112808
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Glycogen Synthase Kinase 3 Beta (Gsk3b) Antibody
abx028354-400ul 400 ul
EUR 627.6

Glycogen Synthase Kinase 3 Beta (Gsk3b) Antibody
abx028354-80l 80 µl
EUR 343.2

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx037712-100ug 100 ug
EUR 469.2

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx125048
  • EUR 594.00
  • EUR 844.80
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 50 ul

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx125336
  • EUR 594.00
  • EUR 844.80
  • EUR 427.20
  • 100 ul
  • 200 ul
  • 50 ul

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx125917
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx328988
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx329709
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx001694
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx002277
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
20-abx004714
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody
abx010856-100ul 100 ul
EUR 493.2

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody
20-abx134166
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody
20-abx121488
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody
20-abx445135
  • EUR 560.40
  • EUR 360.00
  • 100 ug
  • 25 ug

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody
abx033884-400ul 400 ul
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody
abx033884-80l 80 µl
EUR 343.2

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody
20-abx000728
  • EUR 594.00
  • EUR 427.20
  • 100 ul
  • 50 ul

Glycogen synthase kinase-3 beta Antibody / GSK3B
RQ7291 100ug
EUR 419

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody (HRP)
20-abx304084
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ALP)
abx445506-100ug 100 ug
EUR 610.8

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (APC)
abx445507-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (RPE)
abx445513-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody (FITC)
20-abx304085
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (PerCP)
abx445512-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase 3 Beta (GSK3B) Antibody (Biotin)
20-abx304086
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 390)
abx445498-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 488)
abx445499-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 565)
abx445500-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 594)
abx445501-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 633)
abx445502-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 655)
abx445503-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 680)
abx445504-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (ATTO 700)
abx445505-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (Streptavidin)
abx445514-100ug 100 ug
EUR 627.6

Glycogen Synthase Kinase-3 Beta (GSK3B) Antibody (PE/ATTO 594)
abx445511-100ug 100 ug
EUR 644.4

Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human)
4-PAD317Hu01
  • EUR 296.40
  • EUR 3012.00
  • EUR 750.00
  • EUR 372.00
  • EUR 256.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b)

Glycogen Synthase Kinase 3 Beta Phospho-Ser9 (GSK3B pS9) Antibody
abx333187-100ul 100 ul
EUR 560.4

Glycogen Synthase Kinase 3 Beta Phospho-Ser9 (GSK3B pS9) Antibody
20-abx328236
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Glycogen Synthase Kinase 3 Beta Phospho-Ser9 (GSK3B pS9) Antibody
20-abx329723
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Glycogen Synthase Kinase-3 Beta Phospho-Ser9 (GSK3B pS9) Antibody
abx411895-01ml 0.1 ml
EUR 844.8

Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), PE
4-PAD317Hu01-PE
  • EUR 355.20
  • EUR 3168.00
  • EUR 900.00
  • EUR 446.40
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with PE.

Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), APC
4-PAD317Hu01-APC
  • EUR 414.00
  • EUR 3930.00
  • EUR 1094.40
  • EUR 528.00
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with APC.

Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), Cy3
4-PAD317Hu01-Cy3
  • EUR 502.80
  • EUR 5190.00
  • EUR 1410.00
  • EUR 654.00
  • EUR 301.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with Cy3.

Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), HRP
4-PAD317Hu01-HRP
  • EUR 379.20
  • EUR 3426.00
  • EUR 968.40
  • EUR 477.60
  • EUR 247.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with HRP.

Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), FITC
4-PAD317Hu01-FITC
  • EUR 355.20
  • EUR 3168.00
  • EUR 900.00
  • EUR 446.40
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with FITC.

GSK3B siRNA
20-abx918789
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GSK3B siRNA
20-abx918790
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GSK3B siRNA
20-abx902344
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GSK3B Plasmid
PVT7113 2 ug
EUR 319.2

Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), Biotinylated
4-PAD317Hu01-Biotin
  • EUR 373.20
  • EUR 2952.00
  • EUR 872.40
  • EUR 457.20
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with Biotin.

Glycogen Synthase Kinase 3 Beta (GSK3b) Polyclonal Antibody (Human), APC-Cy7
4-PAD317Hu01-APC-Cy7
  • EUR 685.20
  • EUR 7716.00
  • EUR 2046.00
  • EUR 912.00
  • EUR 382.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Glycogen Synthase Kinase 3 Beta (GSK3b). This antibody is labeled with APC-Cy7.

pT7- His- GSK3B
PVT10128 2 ug
EUR 361.2

GSK3B Rabbit mAb
A10877-100ul 100 ul
EUR 460.8

GSK3B Rabbit mAb
A10877-200ul 200 ul
EUR 664.8

GSK3B Rabbit mAb
A10877-20ul 20 ul Ask for price

GSK3B Rabbit mAb
A10877-50ul 50 ul
EUR 318

GSK3B Rabbit pAb
A11360-100ul 100 ul
EUR 369.6

GSK3B Rabbit pAb
A11360-200ul 200 ul
EUR 550.8

GSK3B Rabbit pAb
A11360-20ul 20 ul
EUR 219.6

GSK3B Rabbit pAb
A11360-50ul 50 ul
EUR 267.6

GSK3B Rabbit pAb
A11578-100ul 100 ul
EUR 369.6

GSK3B Rabbit pAb
A11578-200ul 200 ul
EUR 550.8

GSK3B Rabbit pAb
A11578-20ul 20 ul
EUR 219.6

GSK3B Rabbit pAb
A11578-50ul 50 ul
EUR 267.6

GSK3B Rabbit pAb
A16868-100ul 100 ul
EUR 369.6

GSK3B Rabbit pAb
A16868-200ul 200 ul
EUR 550.8

GSK3B Rabbit pAb
A16868-20ul 20 ul
EUR 219.6

GSK3B Rabbit pAb
A16868-50ul 50 ul
EUR 267.6

GSK3B Rabbit pAb
A3174-100ul 100 ul
EUR 369.6

GSK3B Rabbit pAb
A3174-200ul 200 ul
EUR 550.8

GSK3B Rabbit pAb
A3174-20ul 20 ul
EUR 219.6

GSK3B Rabbit pAb
A3174-50ul 50 ul
EUR 267.6

GSK3B Rabbit pAb
A2081-100ul 100 ul
EUR 369.6

GSK3B Rabbit pAb
A2081-200ul 200 ul
EUR 550.8

GSK3B Rabbit pAb
A2081-20ul 20 ul
EUR 219.6

GSK3B Rabbit pAb
A2081-50ul 50 ul
EUR 267.6

GSK3B cloning plasmid
CSB-CL009963HU-10ug 10ug
EUR 568.8
Description: A cloning plasmid for the GSK3B gene.

GSK3B Blocking Peptide
BF0695-BP 1mg
EUR 234

GSK3b Blocking Peptide
33R-10782 50 ug
EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GSK3b antibody, catalog no. 70R-11869

GSK3B Blocking Peptide
DF7231-BP 1mg
EUR 234

Recombinant Human GSK3B
P0221 100ug
EUR 626.83
Description: Recombinant Human protein for GSK3B

pECMV- 3*Flag- GSK3B
PVT10270 2 ug
EUR 361.2

Anti-GSK3B antibody
PAab03673 100 ug
EUR 426

Anti-GSK3B antibody
PAab03674 100 ug
EUR 426
Toxicity on stem and progenitor cell subsets remained minimal. Mixed, our outcomes present a powerful rationale for mixture remedies utilizing the P70S6K inhibitor in MM. Direct and particular inhibition of P70S6K may present an answer for sufferers ineligible or insensitive to dexamethasone or different glucocorticoids.
Tags:
Cell Biology of Canonical Wnt Signaling
The novel AKT inhibitor Afuresertib suppresses human Merkel cell carcinoma MKL-1 cell growth

Leave a Reply

Your email address will not be published. Required fields are marked *